A Phase 1 Study to Assess the Effect of Ketoconazole on the Pharmacokinetics of ABT-199
Phase of Trial: Phase I
Latest Information Update: 02 Nov 2016
At a glance
- Drugs Venetoclax (Primary) ; Ketoconazole
- Indications Non-Hodgkin's lymphoma
- Focus Pharmacokinetics
- Sponsors AbbVie
- 02 Nov 2016 Results published in the British Journal of Clinical Pharmacology
- 21 Oct 2014 Last checked against ClinicalTrials.gov record.
- 15 Oct 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov.